Medical Devices

Public Workshop - Voluntary Medical Device Manufacturing and Product Quality Program - October 10, 2017

The Food and Drug Administration (FDA) is announcing a public workshop entitled "Voluntary Medical Device Manufacturing and Product Quality Program."

The purpose of the workshop is to announce the proposed framework and preliminary outline of a voluntary pilot program that recognizes an independent assessment of manufacturing and product quality. The workshop is intended to discuss the framework of the voluntary pilot program, information on the independent assessment, details of participation, rules of engagement, monitoring and performance expectations, as well as potential modifications to FDA's oversight actions in response to demonstrated manufacturing quality performance. FDA is soliciting public feedback to aid in the development of science-based approaches to regulatory decision making for assessing manufacturing quality, extent of manufacturing related submissions, and how to better allocate resources to lower the regulatory burden on manufacturers and FDA.


Date, Time and Location

This meeting will be held October 10, 2017, beginning at 8:00 a.m. - 5:00 p.m. at the following location:

FDA White Oak Campus
10903 New Hampshire Avenue
Bldg. 31, Room 1503 (the Great Room)
Silver Spring, MD, 20993

Entrance for the public meeting participants (non-FDA employees) is through Building 1 where routine security check procedures will be performed. For parking and security information, please refer to Public Meetings at the FDA White Oak Campus.

Webcast

The meeting will be webcast and the link will be available on this page after October 5, 2017. (Registration is not required to view the webcast).

Agenda

Time Event
7:30 am Registration
Morning Session
(8:00-12:30)
Welcome and Opening Remarks
Office of Compliance Strategic Priorities
Quality Program Pilot Framework
CMMI Institute, Tools, and Playbook
Participation Criteria and Rules of Engagement
12:30-1:30 LUNCH
Afternoon Session
(1:30-5:00)
Introduction to Afternoon Agenda
FDA Modifications to Decrease Regulatory Burden
Value Proposition from Stakeholders
Panel Discussion 1:
Health Outcomes to patients, value to industry, benefits to healthcare
Panel Discussion 2:
Identifying Risks and Mitigation Strategies
Open public session for Presentations by Participants
Closing Remarks

Registration to Attend the Workshop

If you wish to attend this Workshop, you must register by 4:00 p.m. on September 28, 2017.

     Mr. Mrs. Ms. None
*
*   M.D.     Ph.D.
*
Please enter Email again for verification :
*  (No dashes or spaces in phone numbers please)
 *
 * Do you wish to make a presentation? Yes No
 
 
   

There is no fee to register for the Workshop and registration will be on a first-come, first-served basis. Early registration is recommended because seating is limited.

If you wish to speak during the open comment sessions at the meeting you must indicate this at the time of registration. FDA requests that comments focus on the areas defined in the Federal Register Notice. FDA will do its best to accommodate requests to speak.

If you wish to make an oral presentation during any of the open comment sessions at the meeting you must indicate this at the time of registration. FDA requests that presentations focus on the areas defined in the Federal Register Notice. You should also identify which discussion topic you wish to address in your presentation and you must submit a brief statement that describes your experience and/or expertise relevant to your proposed presentation. In order to keep each open session focused on the discussion topic at hand, each oral presentation should address only one discussion topic. FDA will do its best to accommodate requests to speak .

If you require special accommodations due to a disability, or need additional information regarding registration, please contact Peggy Roney, Office of Communication and Education, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Avenue, Bldg. 32, Silver Spring, MD 20993, 301-796-5671, peggy.roney@fda.hhs.gov.

Contact Us

For questions regarding workshop content please contact:

Francisco Vicenty,
Food and Drug Administration,
Center for Devices and Radiological Health,
10903 New Hampshire Ave., Bldg. 66, Room 3426, Silver Spring, MD 20993,
Tele: 301-796-5577,
email: Francisco.Vincenty@fda.hhs.gov

Page Last Updated: 08/04/2017
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English